BPH Treatment Device Market Size, Share & COVID-19 Impact Analysis | Global | 2022-2028 | MedCore

The total global BPH treatment device market is growing at a rate of 5.2%, which will take the 2021 market value of $1.2 billion up to $1.7 billion by 2028. The primary limiter of the BPH treatment device market is the increasing use of pharmaceutical treatments. In 2021, over 90% of BPH patients received drug therapy treatment over interventional methods.

The full report suite on the global market for benign prostatic hyperplasia (BPH) treatment devices includes transurethral resection of the prostate (TURP), laser BPH, UroLift® and Rezum® segments. The TURP market is further segmented into monopolar and bipolar electrodes. The laser BPH market includes high-power Holmium equipment and dedicated fiber, as well as thulium equipment and fiber segments. The UroLift® and Rezum® markets are defined by consumables required for each of the procedure.

MARKET REPORT DATA TYPES INCLUDED

• Procedure Numbers, Unit Sales, Average Selling Prices, Market Value & Growth Trends
• COVID-19 Impact Analysis
• 10 Year Scope and Forecast Range
• Market Drivers & Limiters for Each Segment
• Competitive Analysis with Market Shares for Each Segment
• Recent Mergers & Acquisitions
• Disease Overviews and Demographic Information
• Company Profiles and SWOT for Top Competitors

GLOBAL BPH TREATMENT DEVICE MARKET TRENDS

Both Rezūm® and Urolift® are relatively new treatments for BPH. They are both non-invasive procedures that are being adopted primarily in developed countries such as United States and in Western Europe. These markets are relatively new and many countries have not yet adopted these technologies. As countries begin reimbursing for these treatments, the market will grow significantly.

GLOBAL BPH TREATMENT DEVICE MARKET SHARE INSIGHTS

Overall, within the global BPH treatment device market there are three dominant competitors: Boston Scientific, Teleflex, and Olympus. In 2021, the leading competitor in the BPH treatment device market was Boston Scientific. The company held the dominant leading position in the laser BPH market and a monopolistic position in the Rezūm® market. The company held the second-leading share in North America and was the leading competitor in Western Europe and the rest of the world countries.

MARKET SEGMENTATION SUMMARY

You can view all the included markets and segmentation here:

• TURP Market
• Laser BPH Fibre Market 
• Urolift Market 
• Rezūm Market 

RESEARCH SCOPE SUMMARY

• Regions - North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
• Base Year - 2021
• Forecast - 2022-2028
• Historical Data - 2018-2021
• Quantitative Coverage - Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
• Qualitative Coverage - COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
• Data Sources - Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, Internal Database.